Astellas Pharma Inc.
Company Snapshot
Founded: 1923
Entity Type: Public
Employees: 14,754
Region: U.S.
Revenue: $10,620.0 Millions
Revenue Year: 2023
Headquarter: Tokyo, Japan
Key Geographics: Japan, U.S., Others
Corporate Address: 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, Japan Tel. +81-3-3244-3000 www.astellas.com
Company Overview
Astellas Pharma Inc. was established in 1923 and is headquartered in Tokyo, Japan. Astellas Pharma, one of Japan’s leading prescription drug companies, manufactures products for cardiovascular and diabetes, central nervous system, infectious diseases, inflammation and motor organs, urology and oncology. Astellas conducts business in more than 70 countries and regions around the world.
Financial Highlights (FY 2023)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Company's Business Segments
- XTANDI : For the treatment of prostate cancer
- Betanis/Myrbetriq/BETMIGA : Treatment for overactive bladder (OAB)
- Prograf : Immunosuppressant
Applications/End User Industries
- Healthcare
- Pharmaceuticals
- Oncology
BCC Research Beacon 